Demango Fikre, Tadasa Edosa, Kiya Girum Tesfaye
Department of Medical Laboratory, Bonga Gebretsadik Shawo General Hospital, Bonga, Ethiopia.
School of Medical Laboratory Sciences, Faculty of Health Sciences, Institute of Health, Jimma University, Jimma, Ethiopia.
Adv Hematol. 2025 Aug 21;2025:3894305. doi: 10.1155/ah/3894305. eCollection 2025.
Malaria and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) are widely recognized infectious diseases that pose serious public health challenges in Sub-Saharan Africa and around the globe. A key factor contributing to the rise in human deaths related to malaria and HIV/AIDS is how these diseases can change the hematological parameters in people who are infected with both. Despite the significant effect of malaria and HIV/AIDS on hematological parameters, there are limited data regarding hematological profiles among malaria-HIV coinfected cases. Therefore, this study aimed to determine the hematological profiles of HIV-malaria-coinfected adults receiving highly active antiretroviral therapy at Bonga Gebretsadik Shawo General Hospital. A hospital-based comparative cross-sectional study was conducted among 196 HIV-infected patients (98 HIV-infected and 98 HIV-malaria coinfected) at Bonga General Hospital from 13 June to 3 November 2022. Five milliliters of venous blood samples were collected to detect parasites, estimate parasite density, measure viral load, and perform a complete blood count. Sociodemographic data were collected using structured questionnaires. Data were analyzed using SPSS Version 25. Descriptive statistics, independent samples -tests, and Spearman correlation tests were performed. A value of < 0.05 was set as the cutoff for significance. The study included 196 adults living with HIV. Statistical differences were observed in the mean ± SD values of red blood cells, hemoglobin, and hematocrit ( < 0.05) between HIV-infected and HIV-malaria coinfected study participants. In a total of study participants, significant negative correlations were found between viral load and total white blood cell count, neutrophils, lymphocytes, eosinophils, red blood cells, hemoglobin, hematocrit, mean cell volume, and platelet count. Anemia, leukopenia, and thrombocytopenia were present in 88 (44.9%), 77 (39.3%), and 50 (25.5%) of the 196 participants, respectively. In the HIV-malaria-coinfected group, there was a negative correlation between parasite density and red blood cell count, hemoglobin, hematocrit, and platelets. The prevalence of anemia, leukopenia, and thrombocytopenia among malaria and HIV-coinfected study participants was 60 (61.2%), 43 (43.88%), and 30 (30.6%), respectively. A statistically significant difference ( < 0.001) was observed in the prevalence of anemia between the two groups. The prevalence of anemia was significantly higher in HIV-malaria-coinfected participants than HIV monoinfected paricipants. Mean values of hematological profiles were significantly different in the two groups. Further studies with a larger sample size are needed to support future results.
疟疾和人类免疫缺陷病毒/获得性免疫缺陷综合征(HIV/AIDS)是广为人知的传染病,在撒哈拉以南非洲及全球范围内构成严重的公共卫生挑战。导致与疟疾和HIV/AIDS相关的人类死亡人数上升的一个关键因素是,这些疾病如何改变同时感染这两种疾病的人的血液学参数。尽管疟疾和HIV/AIDS对血液学参数有重大影响,但关于疟疾-HIV合并感染病例的血液学特征的数据有限。因此,本研究旨在确定在邦加·格布雷萨迪克·沙沃综合医院接受高效抗逆转录病毒治疗的HIV-疟疾合并感染成年人的血液学特征。2022年6月13日至11月3日,在邦加综合医院对196名HIV感染患者(98名HIV感染患者和98名HIV-疟疾合并感染患者)进行了一项基于医院的比较横断面研究。采集5毫升静脉血样本以检测寄生虫、估计寄生虫密度、测量病毒载量并进行全血细胞计数。使用结构化问卷收集社会人口统计学数据。使用SPSS 25版进行数据分析。进行描述性统计、独立样本t检验和Spearman相关性检验。将P值<0.05设定为显著性临界值。该研究纳入了196名HIV感染者。在HIV感染和HIV-疟疾合并感染的研究参与者之间,观察到红细胞、血红蛋白和血细胞比容的平均值±标准差存在统计学差异(P<0.05)。在所有研究参与者中,发现病毒载量与总白细胞计数、中性粒细胞、淋巴细胞、嗜酸性粒细胞、红细胞、血红蛋白、血细胞比容、平均细胞体积和血小板计数之间存在显著负相关。196名参与者中,分别有88人(44.9%)、77人(39.3%)和50人(25.5%)出现贫血、白细胞减少和血小板减少。在HIV-疟疾合并感染组中,寄生虫密度与红细胞计数、血红蛋白、血细胞比容和血小板之间存在负相关。疟疾和HIV合并感染的研究参与者中贫血、白细胞减少和血小板减少的患病率分别为6(61.2%)、43(43.88%)和30(30.6%)。两组之间贫血患病率存在统计学显著差异(P<0.001)。HIV-疟疾合并感染参与者的贫血患病率显著高于HIV单感染参与者。两组的血液学特征平均值存在显著差异。需要进一步开展更大样本量的研究以支持未来的结果。